Zygmunt, A.; Krawczyk-Rusiecka, K.; Skowrońska-Jóźwiak, E.; Wojciechowska-Durczyńska, K.; Głowacka, E.; Adamczewski, Z.; Lewiński, A.
The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer. J. Clin. Med. 2021, 10, 4905.
https://doi.org/10.3390/jcm10214905
AMA Style
Zygmunt A, Krawczyk-Rusiecka K, Skowrońska-Jóźwiak E, Wojciechowska-Durczyńska K, Głowacka E, Adamczewski Z, Lewiński A.
The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer. Journal of Clinical Medicine. 2021; 10(21):4905.
https://doi.org/10.3390/jcm10214905
Chicago/Turabian Style
Zygmunt, Arkadiusz, Kinga Krawczyk-Rusiecka, Elżbieta Skowrońska-Jóźwiak, Katarzyna Wojciechowska-Durczyńska, Ewa Głowacka, Zbigniew Adamczewski, and Andrzej Lewiński.
2021. "The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer" Journal of Clinical Medicine 10, no. 21: 4905.
https://doi.org/10.3390/jcm10214905
APA Style
Zygmunt, A., Krawczyk-Rusiecka, K., Skowrońska-Jóźwiak, E., Wojciechowska-Durczyńska, K., Głowacka, E., Adamczewski, Z., & Lewiński, A.
(2021). The Effect of Recombinant Human TSH on Sclerostin and Other Selected Bone Markers in Patients after Total Thyroidectomy for Differentiated Thyroid Cancer. Journal of Clinical Medicine, 10(21), 4905.
https://doi.org/10.3390/jcm10214905
